(R)-[11C]verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticus

S. Syvanen, G. Luurtsema, C.F.M. Molthoff, A.D. Windhorst, M.C. Huisman, A.A. Lammertsma, R.A. Voskuyl, E.C.M. de Lange

    Research output: Contribution to JournalArticleAcademicpeer-review


    Background: Increased functionality of efflux transporters at the blood-brain barrier may contribute to decreased drug concentrations at the target site in CNS diseases like epilepsy. In the rat, pharmacoresistant epilepsy can be mimicked by inducing status epilepticus by intraperitoneal injection of kainate, which leads to development of spontaneous seizures after 3 weeks to 3 months. The aim of this study was to investigate potential changes in P-glycoprotein (P-gp) expression and functionality at an early stage after induction of status epilepticus by kainate.Methods: (R)-[
    Original languageEnglish
    Article number1
    JournalBMC Medical Imaging
    Publication statusPublished - 2011


    Cite this